TRCT
STJ

Tower Research Capital (TRC)’s St Jude Medical STJ Stock Holding History

Tower Research Capital (TRC)’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,987
Closed -$400K – 4585
2016
Q4 		$400K Buy
4,987
+94
+2% +$7.46K 0.04% 410
2016
Q3 		$390K Buy
4,893
+3,665
+298% +$296K 0.04% 226
2016
Q2 		$95K Buy
+1,228
New +$87.6K 0.01% 1136
2016
Q1 		– Sell
-44
Closed -$3K – 5551
2015
Q4 		$3K Sell
44
-2,131
-98% -$134K ﹤0.01% 3623
2015
Q3 		$137K Buy
2,175
+2,075
+2,075% +$148K 0.01% 421
2015
Q2 		$7K Buy
+100
New +$7.22K ﹤0.01% 3059
2015
Q1 		– Sell
-1,666
Closed -$108K – 5310
2014
Q4 		$108K Sell
1,666
-8,527
-84% -$549K 0.01% 568
2014
Q3 		$613K Buy
10,193
+8,969
+733% +$586K 0.07% 218
2014
Q2 		$85K Sell
1,224
-3,121
-72% -$202K 0.01% 992
2014
Q1 		$284K Sell
4,345
-1,513
-26% -$98.5K 0.04% 314
2013
Q4 		$363K Sell
5,858
-628
-10% -$36.4K 0.06% 275
2013
Q3 		$347K Buy
6,486
+5,262
+430% +$271K 0.04% 445
2013
Q2 		$56K Buy
+1,224
New +$53K ﹤0.01% 849

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Tower Research Capital (TRC)'s STJ Position: Q1 2017 in Review

Tower Research Capital (TRC) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,987 shares — an estimated $400K sold.

Tower Research Capital (TRC) first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $613K in Q3 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Tower Research Capital (TRC) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,987 St Jude Medical shares in Q1 2017, an estimated $400K.
  • Tower Research Capital (TRC) first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s St Jude Medical position peaked at $613K in Q3 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.